124 results
ARS
2023 FY
MYGN
Myriad Genetics, Inc.
17 Apr 24
Annual report to shareholders
4:33pm
, operating results or financial condition. We have been subject to a variety of litigation, including a securities class action lawsuit filed in the United … action lawsuit, which was subsequently approved by the United States District Court for the District of Utah on December 15, 2023. Pursuant to the terms
8-K
EX-99.1
3v7abo qyx
27 Feb 24
Results of Operations and Financial Condition
4:05pm
424B5
vy6pluhri5tstfdpvxm4
13 Nov 23
Prospectus supplement for primary offering
6:02am
424B5
he1iv6jt
8 Nov 23
Prospectus supplement for primary offering
4:05pm
S-3ASR
149rjmilld6 8d0ewa
8 Nov 23
Automatic shelf registration
4:01pm
8-K
rohd wo3qcsc
6 Nov 23
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
qnl0w2n9xx1
6 Nov 23
Results of Operations and Financial Condition
4:05pm
8-K
lsgzwe3llt5cvx 9ba
11 Oct 23
Regulation FD Disclosure
9:00am
8-K
EX-10.1
nvm6z02
5 Oct 23
Departure of Directors or Certain Officers
8:30am
8-K
chag 33slp79oozmkhbm
5 Oct 23
Departure of Directors or Certain Officers
8:30am
8-K
uv18kfdsuvrefc
3 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
7qpu3rxaoiz
3 Aug 23
Results of Operations and Financial Condition
4:05pm